<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17561578</article-id>
      <article-id pub-id-type="pmc">2725958</article-id>
      <article-id pub-id-type="publisher-id">06-0755</article-id>
      <article-id pub-id-type="doi">10.3201/eid1304.060755</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Multidrug-resistant <italic>Acinetobacter baumannii</italic>, Russia</article-title>
        <alt-title alt-title-type="running-head">Multidrug-resistant <italic>Acinetobacter baumannii</italic>, Russia</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Naas</surname>
            <given-names>Thierry</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kernbaum</surname>
            <given-names>Serge</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Allali</surname>
            <given-names>Sophie</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nordmann</surname>
            <given-names>Patrice</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <aff id="aff1"><label>*</label>H&#xF4;pital de Bic&#xEA;tre, K.-Bic&#xEA;tre, France</aff>
        <aff id="aff2"><label>&#x2020;</label>American Hospital of Paris, Neuilly-sur-Seine, France</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Thierry Naas, Service de Bact&#xE9;riologie-Virologie, H&#xF4;pital de Bic&#xEA;tre, 78 rue du G&#xE9;n&#xE9;ral Leclerc, 94275 K.-Bic&#xEA;tre Cedex, France; email: <email xlink:href="thierry.naas@bct.ap-hop-paris.fr">thierry.naas@bct.ap-hop-paris.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2007</year>
      </pub-date>
      <volume>13</volume>
      <issue>4</issue>
      <fpage>669</fpage>
      <lpage>671</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>ESBL</kwd>
        <kwd>inter-country spread</kwd>
        <kwd>multidrug resistance</kwd>
        <kwd>carbapenem resistance</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> During the past decade, nosocomial infections due to multidrug-resistant <italic>Acinetobacter baumannii</italic> have been described with increasing frequency, mostly in intensive care units (ICUs), resulting in therapeutic difficulties (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). The main mechanism for resistance to extended-spectrum cephalosporins in <italic>A. baumannii</italic> is attributed to the overexpression of chromosome-encoded cephalosporinases or to plasmid-encoded Ambler class A, B, and D &#x3B2;-lactamases (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). <italic>A. baumannii</italic> that produce PER-1 extended-spectrum &#x3B2;-lactamase (ESBL) are rarely isolated outside Turkey and remain susceptible to carbapenems (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). Here we describe what we believe is the first ESBL-producing <italic>A. baumannii</italic> isolate resistant to carbapenems and the first characterization of a PER-1 <italic>A. baumannii</italic> isolate from Russia, further supporting the emergence and dissemination of PER-1 <italic>A. baumannii</italic> strains in eastern Europe and outside Turkey (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R4"><italic>4</italic></xref>).</p>
    <p>On April 17, 2005, a 79-year-old-man was hospitalized in the cardiology ward of a private hospital in Moscow, Russia, with cardiac arrhythmia and a pulmonary infarction subsequent to a pulmonary embolism. After 1 week, he was transferred to the ICU for multiple organ failure related to a nosocomial infection caused by an <italic>A. baumannii</italic> strain susceptible to several antimicrobial drugs, including imipenem (with positive lung aspiration and blood cultures). He received imipenem and amikacin at high doses. On May 5, 2005, he was transferred to the internal medicine ward of the American Hospital of Paris, Neuilly-sur-Seine, France. On the day of admission, bacterial cultures taken from sputum showed a multidrug-resistant <italic>A. baumannii</italic> MOS-1 strain, susceptible only to colistin and rifampin. The patient received intravenous and aerosolized colistin 3 times a day plus rifampin at 1,200 mg/d so that he could return to Russia. Rapid identification of <italic>A. baumannii</italic> MOS-1, increased awareness as a result of a French national alert signaling the emergence of ESBL VEB-1&#x2013;producing <italic>A. baumannii</italic> (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>), and implementation of strict barrier precautions prevented dissemination of this strain. No other multidrug-resistant <italic>A. baumannii</italic> isolate with a similar resistance profile has been isolated in the hospital before, during, or after this period.</p>
    <p><italic>A. baumannii</italic> MOS-1 was susceptible to colistin and rifampin only, and no synergy image could be observed between clavulanic acid and cefepime or ceftazidime discs on a routine antibiogram performed by the disc diffusion method. Only the use of cloxacillin-containing Mueller-Hinton agar plates (200 &#xB5;g/mL) to inhibit the activity of the naturally occurring cephalosporinase (AmpC) allowed detection of a synergy image, signature of the presence of an ESBL (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>). MICs for imipenem, determined by the agar dilution method (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>), were &gt;64 &#xB5;g/mL. Clavulanic acid addition (2 &#xB5;g/mL) decreased ticarcillin MIC from &gt;512 to 256 &#xB5;g/mL and ceftazidime MIC from 512 to 128 &#xB5;g/mL but did not affect MIC of imipenem.</p>
    <p>Genes coding for ESBLs and for class B and D carbapenemases were sought by PCR as previously described (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R5"><italic>5</italic></xref>). Primers used for detection of TEM and PER &#x3B2;-lactamases gave 894-bp and 825-bp PCR products, respectively (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). Sequence analysis showed identity with <italic>bla</italic><sub>TEM-1</sub> and <italic>bla</italic><sub>PER-1</sub> genes (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). Results of isoelectric focusing showed 3 isoelectric point values (5.3 for PER-1, 5.4 for TEM-1, and &gt;8.5 for AmpC) in <italic>A. baumannii</italic> MOS-1 (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). A crude &#x3B2;-lactamase extract of that isolate had no significant imipenem hydrolysis activity, which suggests that the carbapenem resistance may have emerged through a nonenzymatic mechanism such as mutations in porins (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>). <italic>Bla</italic><sub>PER-1</sub> gene in <italic>A. baumannii</italic> MOS-1 was located on a composite transposon, Tn<italic>1213</italic>, identical to that characterized by Poirel et al. (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). Attempts to demonstrate plasmids or transfer genes encoding TEM-1 or PER-1 failed (data not shown), which suggests that the genes were chromosomally encoded. <italic>A. baumannii</italic> MOS-1 was not clonally related to well-characterized PER-1 <italic>A. baumannii</italic> strains from Turkey, France, and Belgium (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R9"><italic>9</italic></xref>) (<xref ref-type="fig" rid="F1">Figure</xref>), further supporting genetic heterogeneity of PER-1 <italic>A. baumannii</italic> isolates, even though the immediate genetic environment of <italic>bla</italic><sub>PER-1</sub> gene was similar (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>).</p>
    <fig id="F1" fig-type="figure" position="float">
      <label>Figure</label>
      <caption>
        <p>Pulsed-field gel electrophoresis of <italic>Apa</italic>I restricted analysis of <italic>Acinetobacter baumannii</italic> isolates. Lane 1, <italic>A. baumannii</italic> AMA-1 from France (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>); lanes 2 and 3, <italic>A. baumannii</italic> IST-1 and <italic>A. baumannii</italic> IST-2 from Turkey (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>); lane 4, <italic>A. baumannii</italic> isolate from Belgium (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>); and lane 5, <italic>A. baumannii</italic> MOS-1 from Russia (current study). Numbers on the right side of the figure represent the sizes in kb. M, lambda ladder.</p>
      </caption>
      <graphic xlink:href="06-0755-F"/>
    </fig>
    <p>The emergence and spread of ESBL-producing <italic>A. baumannii</italic> strains are of concern because they will increase carbapenem use, thus raising the risk for emergence of carbapenem-resistant isolates. <italic>A. baumannii</italic> MOS-1 is, we believe, the first description of an ESBL-producing <italic>A. baumannii</italic> isolate also being resistant to carbapenems. This resistance was likely acquired in vivo under imipenem treatment, but the susceptible strain was not available for strain comparison. This is also the first description of a PER-1 <italic>A. baumannii</italic> isolate from Russia, a country from which little epidemiologic data on antimicrobial drug resistance are available, except for the emergence of ESBLs of CTX-M type in <italic>Enterobactericeae</italic> (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>).</p>
    <p>This study highlights the importance of international patient transfer in the spread of antimicrobial drug resistance, thus emphasizing the need for hospitals to isolate and screen for multidrug-resistant pathogens in all patients admitted to hospitals from foreign countries. This is particularly critical when the foreign country is known for a high prevalence of multidrug-resistant bacteria or when no antimicrobial drug resistance data are available.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p>Suggested citation for this article: Naas T, Kernbaum S, Allali S, Nordmann P. Multidrug-resistant <italic>Acinetobacter baumannii</italic>, Russia [letter]. Emerg Infect Dis [serial on the Internet]. 2007 Apr [<italic>date cited</italic>]. Available from <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/eid/content/13/4/669.htm">http://www.cdc.gov/eid/content/13/4/669.htm</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <p>This work was funded by a grant from the Minist&#xE8;re de l&#x2019;Education Nationale et de la Recherche (UPRES-EA3539), Universit&#xE9; Paris XI, and by the European Community (6th PCRD, LSHMCT- 2003-503-335).</p>
    </ack>
    <bio>
      <p>Dr Naas is associate professor in microbiology at the University of Paris, South Medical School. His primary research interest is the genetic basis of antimicrobial drug resistance gene acquisition.</p>
    </bio>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="book"><string-name><surname>Allen</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Hartman</surname> <given-names>BJ</given-names></string-name> <italic>Acinetobacter</italic> species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone; <year>2000</year> p. 2339&#x2013;44.</mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Nordmann</surname> <given-names>P</given-names></string-name>, <string-name><surname>Poirel</surname> <given-names>L</given-names></string-name> <article-title>Emerging carbapenemases in gram-negative aerobes.</article-title><source>Clin Microbiol Infect</source> <year>2002</year>;<volume>8</volume>:<fpage>321</fpage>&#x2013;<lpage>31</lpage> <pub-id pub-id-type="doi">10.1046/j.1469-0691.2002.00401.x</pub-id><pub-id pub-id-type="pmid">12084099</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Kolayli</surname> <given-names>F</given-names></string-name>, <string-name><surname>Gacar</surname> <given-names>G</given-names></string-name>, <string-name><surname>Karadenizli</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sanic</surname> <given-names>A</given-names></string-name>, <string-name><surname>Vahaboglu</surname> <given-names>H</given-names></string-name>; <collab>The Study Group.</collab><article-title>PER-1 is still widespread in Turkish hospitals among <italic>Pseudomonas aeruginosa</italic> and <italic>Acinetobacter</italic> spp.</article-title><source>FEMS Microbiol Lett</source> <year>2005</year>;<volume>249</volume>:<fpage>241</fpage>&#x2013;<lpage>5</lpage> <pub-id pub-id-type="doi">10.1016/j.femsle.2005.06.012</pub-id><pub-id pub-id-type="pmid">16006075</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Naas</surname> <given-names>T</given-names></string-name>, <string-name><surname>Bogaerts</surname> <given-names>P</given-names></string-name>, <string-name><surname>Bauraing</surname> <given-names>C</given-names></string-name>, <string-name><surname>Degheldre</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Glupczynski</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Nordmann</surname> <given-names>P</given-names></string-name> <article-title>Emergence of PER and VEB extended-spectrum beta-lactamases in <italic>Acinetobacter baumannii</italic> in Belgium.</article-title><source>J Antimicrob Chemother</source> <year>2006</year>;<volume>58</volume>:<fpage>178</fpage>&#x2013;<lpage>82</lpage> <pub-id pub-id-type="doi">10.1093/jac/dkl178</pub-id><pub-id pub-id-type="pmid">16670107</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Naas</surname> <given-names>T</given-names></string-name>, <string-name><surname>Coignard</surname> <given-names>B</given-names></string-name>, <string-name><surname>Carbonne</surname> <given-names>A</given-names></string-name>, <string-name><surname>Blanckaert</surname> <given-names>K</given-names></string-name>, <string-name><surname>Bajolet</surname> <given-names>O</given-names></string-name>, <string-name><surname>Bernet</surname> <given-names>C</given-names></string-name>, <etal/><article-title>VEB-1 extended-spectrum &#x3B2;-lactamase&#x2013;producing <italic>Acinetobacter baumannii</italic>, France.</article-title><source>Emerg Infect Dis</source> <year>2006</year>;<volume>12</volume>:<fpage>1214</fpage>&#x2013;<lpage>22</lpage><pub-id pub-id-type="pmid">16965700</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="other"><collab>Clinical and Laboratory Standards Institute</collab> Performance standards for antimicrobial susceptibility testing: 15th informational supplement. M100-S15. Wayne (PA): Clinical and Laboratory Standards Institute; <year>2005</year> </mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Fern&#xE1;ndez-Cuenca</surname> <given-names>F</given-names></string-name>, <string-name><surname>Mart&#xED;nez-Mart&#xED;nez</surname> <given-names>L</given-names></string-name>, <string-name><surname>Conejo</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Ayala</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Perea</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Pascual</surname> <given-names>A</given-names></string-name> <article-title>Relationship between &#x3B2;-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of <italic>Acinetobacter baumannii.</italic></article-title><source>J Antimicrob Chemother</source> <year>2003</year>;<volume>51</volume>:<fpage>565</fpage>&#x2013;<lpage>74</lpage> <pub-id pub-id-type="doi">10.1093/jac/dkg097</pub-id><pub-id pub-id-type="pmid">12615856</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Poirel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Cabanne</surname> <given-names>L</given-names></string-name>, <string-name><surname>Vahaboglu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Nordmann</surname> <given-names>P</given-names></string-name> <article-title>Genetic environment and expression of the extended-spectrum beta-lactamase <italic>bla</italic><sub>PER-1</sub> gene in gram-negative bacteria.</article-title><source>Antimicrob Agents Chemother</source> <year>2005</year>;<volume>49</volume>:<fpage>1708</fpage>&#x2013;<lpage>13</lpage> <pub-id pub-id-type="doi">10.1128/AAC.49.5.1708-1713.2005</pub-id><pub-id pub-id-type="pmid">15855485</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Tenover</surname> <given-names>FC</given-names></string-name>, <string-name><surname>Arbeit</surname> <given-names>RD</given-names></string-name>, <string-name><surname>Goering</surname> <given-names>RV</given-names></string-name>, <string-name><surname>Mickelsen</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Murray</surname> <given-names>BE</given-names></string-name>, <string-name><surname>Persing</surname> <given-names>DH</given-names></string-name>, <etal/><article-title>Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.</article-title><source>J Clin Microbiol</source> <year>1995</year>;<volume>33</volume>:<fpage>2233</fpage>&#x2013;<lpage>9</lpage><pub-id pub-id-type="pmid">7494007</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Edelstein</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pimkin</surname> <given-names>M</given-names></string-name>, <string-name><surname>Palagin</surname> <given-names>I</given-names></string-name>, <string-name><surname>Edelstein</surname> <given-names>I</given-names></string-name>, <string-name><surname>Stratchounski</surname> <given-names>L</given-names></string-name> <article-title>Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing <italic>Escherichia coli</italic> and <italic>Klebsiella pneumoniae</italic> in Russian hospitals.</article-title><source>Antimicrob Agents Chemother</source> <year>2003</year>;<volume>47</volume>:<fpage>3724</fpage>&#x2013;<lpage>32</lpage> <pub-id pub-id-type="doi">10.1128/AAC.47.12.3724-3732.2003</pub-id><pub-id pub-id-type="pmid">14638473</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
